SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SIMIONI, Carolina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.457
EU - Europa 1.212
AS - Asia 433
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.440
PL - Polonia 500
IT - Italia 294
CN - Cina 234
UA - Ucraina 110
DE - Germania 108
TR - Turchia 77
GB - Regno Unito 68
SG - Singapore 50
SE - Svezia 48
FI - Finlandia 28
VN - Vietnam 26
ID - Indonesia 25
CA - Canada 16
FR - Francia 14
BE - Belgio 12
RU - Federazione Russa 12
CZ - Repubblica Ceca 5
HK - Hong Kong 5
TW - Taiwan 4
ES - Italia 3
HU - Ungheria 3
IN - India 3
IR - Iran 3
CH - Svizzera 2
EU - Europa 2
IE - Irlanda 2
RO - Romania 2
SA - Arabia Saudita 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
DZ - Algeria 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
KR - Corea 1
MX - Messico 1
PT - Portogallo 1
Totale 4.110
Salva come PNG Salva come JPEG
Città #
Warsaw 500
Fairfield 383
Woodbridge 280
Houston 214
Ashburn 172
Chandler 171
Ann Arbor 156
Seattle 152
Ferrara 146
Cambridge 144
Wilmington 139
Jacksonville 127
Izmir 54
Princeton 49
Nanjing 46
Beijing 42
Milan 41
Shanghai 33
San Diego 29
Singapore 28
Boardman 25
Dearborn 24
Dong Ket 24
Jakarta 24
Munich 18
Nanchang 18
Shenyang 18
Brussels 12
Los Angeles 12
Montréal 12
Changsha 11
New York 11
Auburn Hills 10
Hebei 8
Jinan 8
Kunming 8
Bologna 7
Bremen 7
Redwood City 7
Addison 6
Falls Church 6
Norwalk 6
Redmond 6
Tianjin 6
Des Moines 5
Guangzhou 5
Hefei 5
Imola 5
London 5
Zhengzhou 5
Augusta 4
Cagliari 4
Forlì 4
Hong Kong 4
Mcallen 4
Mountain View 4
Taipei 4
Washington 4
Albuquerque 3
Budapest 3
Catania 3
Ferrara di Monte Baldo 3
Hangzhou 3
Helsinki 3
Lanzhou 3
Lappeenranta 3
Ningbo 3
Ottawa 3
Phoenix 3
San Mateo 3
Tappahannock 3
Bassano Del Grappa 2
Castel San Pietro Terme 2
Civitanova Marche 2
Focsani 2
Hanoi 2
Jeddah 2
Jiaxing 2
Kilburn 2
Mainz 2
Marseille 2
Notaresco 2
Olomouc 2
Orange 2
Paris 2
Philadelphia 2
Rome 2
Saint-Fons 2
Taizhou 2
Adelaide 1
Ardabil 1
Ariano nel Polesine 1
Baotou 1
Bari 1
Brno 1
Buffalo 1
Casalecchio di Reno 1
Castenaso 1
Catanzaro 1
Ceilândia 1
Totale 3.348
Salva come PNG Salva come JPEG
Nome #
Targeting mTOR in Acute Lymphoblastic Leukemia 209
PHARMACOLOGICAL CHARACTERIZATION OF THE SIGNAL TRANSDUCTION PATHWAYS MODULATED BY A3 RECEPTORS IN CANCER CELLS: POSSIBLE TARGETS FOR THERAPEUTIC INTERVENTION. 182
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 176
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 165
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 158
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 149
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 145
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 145
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 141
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 137
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 134
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 126
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential. 125
Adenosine receptors and cancer 120
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 119
null 112
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 104
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 101
null 95
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 93
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 90
null 86
null 86
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 84
null 84
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 83
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 82
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 77
PI3K/Akt/mTOR Pathway in Acute Lymphoblastic Leukemia Targeted Therapies 70
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 65
VEGF and IL-8 regulation by cytotoxic drugs in human melanoma cells: molecular mechanism modulated by A2B and A3 adenosine receptors 60
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS 59
Binding thermodynamics at the human A2B adenosine receptor. 58
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 57
The mTOR inhibitor, RAD001, displays higher cytotoxicity in leukemias with hyperactivated PI3K/AKT/mTOR pathway 45
The novel Akt inhibitor MK-2206, is cytotoxic in T-cell acute lymphoblastic leukemia: Therapeutic implications 45
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation. 41
Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL). 40
Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives 32
Legislation to limit the environmental plastic and microplastic pollution and their influence on human exposure 32
The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies 29
Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage 28
Optical tissue clearing associated with 3D imaging: application in preclinical and clinical studies 28
Micrornas patterns as potential tools for diagnostic and prognostic follow‐up in cancer survivorship 25
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 23
The role of extracellular vesicles as shuttles of RNA and their clinical significance as biomarkers in hepatocellular carcinoma 23
A2B AND A3 ADENOSINE RECEPTORS MODULATE VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 EXPRESSION IN HUMAN MELANOMA CELLS TREATED WITH ETOPOSIDE AND DOXORUBICIN. 21
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation. 18
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 14
Microalgae as a Nutraceutical Tool to Antagonize the Impairment of Redox Status Induced by SNPs: Implications on Insulin Resistance 13
Regulation of Second Messenger Systems and Intracellular Pathways. 13
The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy 11
Totale 4.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 692
Totale 18.064
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.054 117 41 44 126 77 127 111 109 106 92 51 53
2020/20211.026 60 78 54 79 132 106 67 98 46 169 69 68
2021/2022434 20 35 21 4 36 36 13 35 15 47 55 117
2022/2023467 55 36 26 42 60 49 42 31 45 30 37 14
2023/2024299 28 35 22 6 15 29 19 22 5 10 15 93
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 4.258